Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (22.616)

21

Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China : a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial

enthalten in: The journal of headache and pain | 2024

von Yu, S. | Guo, A. | Wang, Z. | +12

22

68Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer : a single-centre, single-arm, phase 2/3 imaging trial

enthalten in: The Lancet. Oncology | 2024

von Duan, H. | Moradi, F. | Davidzon, G. | +8

23

Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring

enthalten in: The Journal of infectious diseases | 2024

von Stalter, R. | Dong, T. | Hendrix, C. | +30

24

Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis : a post hoc analysis of a phase 3b/4 randomised safety study

enthalten in: RMD open | 2024

von Buch, M. | Bhatt, D. | Charles-Schoeman, C. | +10

25

Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia : analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial

enthalten in: The Lancet. Oncology | 2024

von Kater, A. | Arslan, �. | Demirkan, F. | +24

26

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Wu, Y. | Dziadziuszko, R. | Ahn, J. | +120

27

Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia : a randomized phase 3 trial with 5-year outcomes

enthalten in: Journal of cancer research and clinical oncology | 2024

von Tian, J. | Song, Y. | Zhang, G. | +24

28

Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal : an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

enthalten in: The Lancet. Global health | 2024

von Song, K. | Chapagain, R. | Tamrakar, D. | +24

29

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Park, S. | Kim, T. | Han, J. | +21

30

Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer : Phase III ERMES Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Pinto, C. | Orlandi, A. | Normanno, N. | +17